Related references
Note: Only part of the references are listed.Effect of intravitreal bevacizumab (Avastin®) in neovascular age-related macular degeneration using a treatment regimen based on optical coherence tomography: 6-and 12-month results
Christina Leydolt et al.
ACTA OPHTHALMOLOGICA (2010)
Effects on Choroidal Neovascularization after Anti-VEGF Upload Using Intravitreal Ranibizumab, as Determined by Spectral Domain-Optical Coherence Tomography
Carsten Framme et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Effects of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Attributable to Age-related Macular Degeneration
Simon P. Rothenbuehler et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
Geeta A. Lalwani et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
The As-Needed Treatment Strategy for Choroidal Neovascularization: A Feedback-Based Treatment System
Richard F. Spaide
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective Study
Ziad F. Bashshur et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
OCT-based re-injections for anti-VEGF-treatment for neovascular ARMD
K. B. Schaal et al.
OPHTHALMOLOGE (2009)
Influence of antiangiogenetic therapy on retinal thickness values in age-related macular degeneration
I. Golbaz et al.
OPHTHALMOLOGE (2009)
Comparison of Spectral-Domain versus Time-Domain Optical Coherence Tomography in Management of Age-Related Macular Degeneration with Ranibizumab
Kaori Sayanagi et al.
OPHTHALMOLOGY (2009)
Evaluation of Ranibizumab-Induced Changes in High-Resolution Optical Coherence Tomographic Retinal Morphology and Their Impact on Visual Function
Christopher G. Kiss et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1
Carl D. Regillo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration
Pearse A. Keane et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natural course of occult choroidal neovascularization in age-related macular degeneration: development of classic lesions in fluorescein angiography
U Schneider et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2005)
Share Paper
